Department of Cellular and Genetic Medicine, Binzhou Medical University, Yantai, 264003, China.
Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou 256603, China.
Curr Gene Ther. 2024;24(5):395-409. doi: 10.2174/0115665232284076240207073542.
Pulmonary fibrosis is a class of fibrosing interstitial lung diseases caused by many pathogenic factors inside and outside the lung, with unknown mechanisms and without effective treatment. Therefore, a comprehensive understanding of the molecular mechanism implicated in pulmonary fibrosis pathogenesis is urgently needed to develop new and effective measures. Although circRNAs have been widely acknowledged as new contributors to the occurrence and development of diseases, only a small number of circRNAs have been functionally characterized in pulmonary fibrosis. Here, we systematically review the biogenesis and functions of circRNAs and focus on how circRNAs participate in pulmonary fibrogenesis by influencing various cell fates. Meanwhile, we analyze the current exploration of circRNAs as a diagnostic biomarker, vaccine, and therapeutic target in pulmonary fibrosis and objectively discuss the challenges of circRNA- based therapy for pulmonary fibrosis. We hope that the review of the implication of circRNAs will provide new insights into the development circRNA-based approaches to treat pulmonary fibrosis.
肺纤维化是一类由肺内外多种致病因素引起的纤维性间质性肺疾病,发病机制不明,尚无有效治疗手段。因此,迫切需要全面了解肺纤维化发病机制中涉及的分子机制,以开发新的有效措施。尽管 circRNAs 已被广泛认为是疾病发生和发展的新贡献者,但在肺纤维化中仅有少数 circRNAs 具有功能特征。在这里,我们系统地综述了 circRNAs 的生物发生和功能,并重点讨论了 circRNAs 通过影响各种细胞命运参与肺纤维化的机制。同时,我们分析了 circRNAs 作为肺纤维化诊断生物标志物、疫苗和治疗靶点的当前探索,并客观讨论了基于 circRNA 的肺纤维化治疗的挑战。我们希望 circRNAs 作用的综述将为基于 circRNA 的方法治疗肺纤维化提供新的见解。